APA (7th ed.) Citation

BR, Z., E, P., M, D., J, M., L, P., V, R., . . . R, L. (2025). Associations of MEG3 rs7158663, rs4081134 gene variants and Ki-67, p53, CK18 immunohistochemical markers with clinical features of pituitary neuroendocrine tumors. Frontiers in endocrinology, 16, 1657520. https://doi.org/10.3389/fendo.2025.1657520

Chicago Style (17th ed.) Citation

BR, Zaliunas, Pileckaite E, Duseikaite M, Makstiene J, Poskiene L, Rovite V, Wu SN, Tamasauskas A, and Liutkeviciene R. "Associations of MEG3 Rs7158663, Rs4081134 Gene Variants and Ki-67, P53, CK18 Immunohistochemical Markers with Clinical Features of Pituitary Neuroendocrine Tumors." Frontiers in Endocrinology 16 (2025): 1657520. https://doi.org/10.3389/fendo.2025.1657520.

MLA (9th ed.) Citation

BR, Zaliunas, et al. "Associations of MEG3 Rs7158663, Rs4081134 Gene Variants and Ki-67, P53, CK18 Immunohistochemical Markers with Clinical Features of Pituitary Neuroendocrine Tumors." Frontiers in Endocrinology, vol. 16, 2025, p. 1657520, https://doi.org/10.3389/fendo.2025.1657520.